NOX4 and diabetes mellitus: If Nox4 is shown to be involved in the aging process in the heart, it could be a promising target of pharmacological intervention because aging-induced cardiomyopathy remarkably enhances the patient's risk of developing heart failure in response to many cardiac conditions, including high blood pressure, ischemia, and diabetes.